| Literature DB >> 34858883 |
Yuying Chen1,2, Mingming Zhang3, Xin Ding2, Yougui Yang1,2, Yujia Chen3, Qiang Zhang2, Yinwen Fan4, Yang Dai1,2, Junhong Wang3,4.
Abstract
Hookworm is one type of soil-transmitted helminth, which could exert an anti-inflammatory effect in human or animal host, which provides a beneficial possibility for the discovery of inflammatory-related disease interventions. The identification of hookworm-derived anti-inflammatory molecules is urgently needed for future translational research. The emergence of metabolomics has become a powerful approach to comprehensively characterize metabolic alterations in recent times. Herein, excretory and secretory products (ESPs) were collected from cultured adult worm, while small intestinal contents were obtained from Nippostrongylus brasiliensis (N. brasiliensis, Nb)-infected mice. Through ultra-high-performance liquid chromatography coupled with mass spectrometry (UHPLC-MS) platform, metabolomics analysis was used to explore the identification of anti-inflammatory molecules. Out of 45 differential metabolites that were discovered from ESPs, 10 of them showed potential anti-inflammatory properties, which could be subclassed into amino acids, furanocoumarins, linear diarylheptanoids, gamma butyrolactones, and alpha-keto acids. In terms of intestinal contents that were derived from N. brasiliensis-infected mice, 14 out of 301 differential metabolites were discovered to demonstrate anti-inflammatory effects, with possible subclassification into amino acids, benzylisoquinolines, quaternary ammonium salts, pyrimidines, pregnane steroids, purines, biphenyls, and glycerophosphocholines. Furthermore, nine of the differential metabolites appeared both in ESPs and infected intestinal contents, wherein four were proven to show anti-inflammation properties, namely, L-glutamine, glutamine (Gln), pyruvate, and alanine-Gln (Ala-Gln). In summary, we have provided a method for the identification and analysis of parasite-derived molecules with potential anti-inflammatory properties in the present study. This array of anti-inflammatory metabolites could provide clues for future evaluation and translational study of these anti-inflammatory molecules.Entities:
Keywords: Nippostrongylus brasiliensis; anti-inflammatory activity; hookworm; host–pathogen interactions; metabolomics approach
Mesh:
Substances:
Year: 2021 PMID: 34858883 PMCID: PMC8632049 DOI: 10.3389/fcimb.2021.781132
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Schematic flowchart, OPLS-DA score plots, and corresponding permutation tests in positive and negative modes of the present study. Schematic flowchart of metabolomic analysis for ESPs and intestinal content from Nb-infected mice (A). The scatter plots of the OPLS-DA score of ion mode: (B, F) positive and (D, H) negative. The results of the permutation test of ion mode: (C, G) positive and (E, I) negative.
Figure 3Heatmaps of different metabolites within the Nb and ES groups. (A, C) show the positive ion mode and (B, D) show the negative ion mode. The significance of metabolite change (red denotes upregulated and blue indicates downregulated) was proportional to the color of each section. Rows correspond to metabolites, while columns correspond to samples.
Figure 2Unique and common differential metabolites in Nb vs. NC and ES vs. ES-blank groups. The volcano maps of differential metabolites of positive (A, C) and negative (B, D) ion modes. Red scatters denote the upward trend in metabolites, blue scatters indicate the downward trend in metabolites, and black scatters show the non-significant trend in metabolites. The chemical classification chart of distinct metabolites in the Nb (E) and ES groups (F) as well as common and unique metabolite distribution within the two sample groups (G). Different colors in the picture indicate distinct chemical classifications. Percentage represents the proportion of the metabolite number in the chemical classification to the total metabolite number. The Venn diagram shows the overlap of the significantly different metabolites. Two circles were used to denote the clustering of the entire distinctly expressed metabolites into two comparison groups. The number of distinctly expressed metabolites in one comparison group was taken as the sum of the entire figures represented in one circle.
List of the common differential metabolites in Nb vs. NC and ES vs. ES-blank.
| ESI mode | Metabolites | Superclass |
| rt (s) | ES vs. ES-blank | Nb vs. NC | ||
|---|---|---|---|---|---|---|---|---|
| VIP |
| VIP |
| |||||
| + | L-Glutamine | Organic acids and derivatives | 169.057 | 373.919 | 7.297 | 0.002 | 1.028 | 0.006 |
| + | Ile-Gly-Ile | Organic acids and derivatives | 302.205 | 211.549 | 1.703 | 0.009 | 2.989 | 0.000 |
| + | Thymine | Organoheterocyclic compounds | 127.050 | 97.825 | 2.059 | 0.001 | 7.988 | 0.006 |
| + | D-pyroglutamic acid | Organic acids and derivatives | 130.049 | 374.519 | 10.833 | 0.015 | 2.103 | 0.018 |
| − | Glutamine | Organic acids and derivatives | 145.062 | 374.131 | 7.870 | 0.036 | 2.012 | 0.009 |
| − | Pyruvate | Organic acids and derivatives | 87.008 | 130.075 | 1.791 | 0.049 | 1.237 | 0.001 |
| − | Ala-Gln | Organic acids and derivatives | 216.099 | 354.041 | 10.097 | 0.002 | 1.357 | 0.001 |
| − | Ser-Asn | Organic acids and derivatives | 218.078 | 368.522 | 1.282 | 0.006 | 1.013 | 0.021 |
| − | 9,10-Dihydroxy-12z-octadecenoic acid | Lipids and lipid-like molecules | 313.239 | 78.357 | 3.041 | 0.031 | 5.962 | 0.015 |
ESI mode: +, positive ion mode; −, negative ion mode.
m/z, mass-to-charge ratio; rt, retention time; VIP, variable importance in the projection; FC, fold change.
Summary table of differential metabolites with pharmacological activity.
| Name | Superclass |
| rt (s) | Reported pharmacological activities | ES | Nb | ||
|---|---|---|---|---|---|---|---|---|
| VIP |
| VIP |
| |||||
| Ala-Gln | Organic acids and derivatives | 216.099 | 354.041 | Improved intestinal immunity ( | 10.097 | 0.002 | 1.357 | 0.001 |
| Pyruvate | Organic acids and derivatives | 87.008 | 130.075 | Anti-inflammatory ( | 1.791 | 0.049 | 1.237 | 0.001 |
| Glutamine | Organic acids and derivatives | 145.062 | 374.131 | Anti-inflammatory ( | 7.87 | 0.036 | 2.012 | 0.009 |
| L-Glutamine | Organic acids and derivatives | Su | 373.919 | Anti-inflammatory ( | 7.297 | 0.002 | 1.028 | 0.006 |
| Betaine | Organic acids and derivatives | 118.085 | 274.605 | Neuroprotective ( | 5.896 | 0.000 | ||
| Bergaptol | Phenylpropanoids and polyketides | 203.051 | 302.917 | Anti-inflammatory ( | 3.794 | 0.014 | ||
| Gamma-L-glutamyl-L-valine | Organic acids and derivatives | 227.104 | 377.969 | Anti-inflammatory ( | 1.659 | 0.002 | ||
| Curcumin | Phenylpropanoids and polyketides | 367.106 | 305.841 | Antiproliferative ( | 15.442 | 0.011 | ||
| Phenylalanine | Organic acids and derivatives | 164.072 | 257.387 | Improved intestinal immunity ( | 1.902 | 0.026 | ||
| D-saccharic acid 1,4-lactone | Organoheterocyclic compounds | 190.995 | 307.027 | Anti-inflammatory ( | 1.013 | 0.043 | ||
| Olanzapine | 157.096 | 252.236 | Anti-inflammatory ( | 1.452 | 0.001 | |||
| Papaverine | Organoheterocyclic compounds | 340.145 | 370.151 | Anti-inflammatory ( | 1.083 | 0.001 | ||
| Carnitine | Organic nitrogen compounds | 162.111 | 356.015 | Anti-inflammatory ( | 5.629 | 0.001 | ||
| Thiamine | Organoheterocyclic compounds | 283.124 | 360.263 | Anti-inflammatory ( | 2.017 | 0.002 | ||
| Pregnenolone | Lipids and lipid-like molecules | 317.245 | 32.036 | Anti-inflammatory ( | 1.21 | 0.006 | ||
| Adenine | Organoheterocyclic compounds | 136.06 | 142.232 | Anti-inflammatory ( | 2.228 | 0.007 | ||
| Irbesartan | Benzenoids | 429.258 | 151.72 | Antioxidant ( | 2.962 | 0.008 | ||
| PC(16:0/16:0) | Lipids and lipid-like molecules | 756.548 | 147.302 | Anti-inflammatory ( | 2.02 | 0.022 | ||
| Gamma-aminobutyric acid | Organic acids and derivatives | 180.1 | 38.032 | Gastroprotective ( | 2.328 | 0.046 | ||
| Arginine | Organic acids and derivatives | 175.117 | 301.295 | Anti-inflammatory ( | 1.583 | 0.048 | ||
Figure 4Bubble plot of the pathway analysis of Nb vs. NC (A) and ES vs. ES-blank (B). A metabolic pathway is represented by each bubble in the bubble chart. In the topological analysis, the pathway is influenced by factors such as the size and abscissa of the bubble. The ordinate and color of the bubble with the latter indicating the p-value of the enrichment analysis. The darker the color, the smaller the p-value and the more significant the enrichment degree. The rich factor represents the ratio of the different metabolites in the pathway to the detected metabolites.